to characterize the effects of a new calcium antagonist of the dihydropyridine type , 1,4-dihydro-2,6-dimethyl-4- ( 3-nitrophenyl ) -3,5-pyridinedicarboxylic++ + acid methyl 6- ( 5-phenyl-3-pyrazolyloxy ) hexyl ester ( cv-159 ) on the cardiovascular system , experiments were performed in the anesthetized open-chest dogs and in the heart-lung preparation with a support dog in comparison with those of nicardipine .
C2945601
calcium antagonist
C0028005
nicardipine